| Aug 14 |
Protalix BioTherapeutics, Inc. (PLX) Q2 2024 Earnings Call Transcript
|
| Aug 14 |
Protalix: Q2 Earnings Snapshot
|
| Aug 14 |
Protalix BioTherapeutics GAAP EPS of -$0.03 misses by $0.05, revenue of $13.47M beats by $0.97M
|
| Aug 14 |
Protalix BioTherapeutics Reports Second Quarter 2024 Financial and Business Results
|
| Aug 13 |
Protalix BioTherapeutics Q2 Earnings Preview
|
| Aug 7 |
Protalix BioTherapeutics to Announce Second Quarter 2024 Financial and Business Results on August 14, 2024
|
| Jun 13 |
Protalix BioTherapeutics to Host In-Person Investor Day to Discuss Current Treatment Landscapes and Clinical Results for Fabry Disease and Uncontrolled Gout
|
| May 29 |
Protalix BioTherapeutics to Present at the 2024 BIO International Convention
|
